Table I.
Description of the population participating in each of the 3 surveys: (1) visual impact of large/giant congenital melanocytic naevi (LGCMN); (2) visual impact of scarring; (3) comparison of the impact of LGCMN and scarring
| Total n = 1,015a | Population survey 1 n = 125 | Population survey 2 n = 522 | Population survey 3 n = 418 | |
|---|---|---|---|---|
| Age, years, mean (SD) | 41 (11.0) | 41.0 (12.3) | 41.0 (11.0) | 40.3 (10.8) |
| Range | 18–72 | 21–72 | 18–68 | 18–72 |
| Sex, n (%) | ||||
| Male | 348 (34.3) | 21 (28.0) | 162 (31.0) | 165 (39.5)* |
| Female | 667 (65.7) | 54 (72.0) | 360 (69.0) | 253 (60.5) |
| Marital status, n (%) | ||||
| Single | 271 (26.8) | 21 (22.0) | 142 (27.4) | 108 (25.8) |
| With partner | 641 (63.3) | 50 (66.7) | 327 (63.0) | 264 (63.2) |
| Separated/divorced | 93 (9.2) | 3 (4.0) | 47 (9.0) | 43 (10.3) |
| Widow/er | 7 (0.7) | 1 (1.3) | 3 (0.6) | 3 (0.7) |
| Education, n (%) | ||||
| Primary school | 5 (0.5) | 0 (0.0) | 3 (0.6) | 2 (0.5)** |
| Secondary school | 33 (3.2) | 3 (4.0) | 18 (3.4) | 12 (2.9) |
| High-school | 228 (22.5) | 17 (22.7) | 134 (25.7) | 77 (18.5) |
| Professional education, n (%) | ||||
| University | 566 (55.8) | 38 (50.6) | 289 (55.4) | 239 (57.3) |
| PhD | 182 (18.0) | 17 (22.7) | 78 (14.9) | 87 (20.9) |
| Occupation, n (%) | ||||
| No healthcare | 349 (34.9) | 27 (43.5) | 176 (35.1) | 146 (37.8) |
| Healthcare provider | 600 (65.1) | 35 (56.5) | 325 (64.9) | 240 (62.2) |
| Having children, n (%) | ||||
| Yes | 549 (45.8) | 38 (51.4) | 277 (53.2) | 234 (56.1) |
| No | 463 (54.2) | 36 (48.6) | 244 (46.8) | 183 (43.9) |
| History of personal or familial neoplasiab, n (%) | ||||
| Yes | 637 (63.6) | 53 (70.7) | 336 (64.7) | 248 (62.0) |
| No | 364 (36.4) | 22 (29.3) | 183 (35.3) | 159 (38.0) |
| Disfiguring skin conditionc, n (%) | ||||
| Yes | 133 (13.3) | 12 (16.0) | 60 (11.5) | 61 (15.0) |
| No | 870 (86.7) | 63 (84.0) | 460 (88.5) | 347 (85.0) |
a
Totals may vary because of missing figures.
b
Relative or participant her/himself with any kind of tumour/neoplasia.
c
Relative or participant her/himself with any kind of disfiguring skin condition.
*
p < 0.05 compared with population 2;
**
p < 0.05 compared with population 2.